Breast cancer is the second most common types of cancer worldwide. Molecular strategies have developed rapidly; however, novel treatments strategies with high efficacy and lower toxicity are still urgently demanded.
Notably, biological networks estimated from microarraydata and functional activity network analysis could be utilized to identify and validate potential targets. In this study, two microarraydata (GSE13477, GSE31192) were firstly selected, and analyzed by multi-functional activity network analysis to generate the core protein-protein-interaction (PPI) network.
Several potential targets were subsequently identified and c-Met and poly (ADP-ribose) polymerase-1 (PARP-1) were manually chosen as the key targets in breast cancer. Furthermore, virtual screening and molecular dynamics (MD) simulations were utilized to recognize novel c-Met/PARP-1 inhibitors in Specs products database.
Three small molecules, namely, ZINC19909930, ZINC20032678 and ZINC13562414 were selected. Additionally, these compounds were synthesized, and two breast cancer cell lines, MDA-MB-231 and MCF-7 cells were used to validate our bioinformatic findings in vitro. MTT assay and Hoechst staining showed that ZINC20032678 significantly induced breast cancer cell death, which was mediated through apoptosis by flow cytometry.
Furthermore, ZINC20032678 was shown to target the active sites of the both targets and recruitment of downstream apoptotic signaling pathways, eventually inducing breast cancer cell apoptosis.
AES Protein |
20-abx262697 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
AES Peptide |
42-365P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (NT) AES Peptide |
AES Peptide |
3607P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) AES peptide |
AES Peptide |
3609P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) AES peptide |
AES Antibody |
24349-100ul |
SAB |
100ul |
EUR 468 |
AES Antibody |
24350-100ul |
SAB |
100ul |
EUR 468 |
AES antibody |
70R-1059 |
Fitzgerald |
100 ug |
EUR 452.4 |
Description: Rabbit polyclonal AES antibody raised against the C terminal of AES |
AES antibody |
70R-7912 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Affinity purified rabbit polyclonal AES antibody |
AES Antibody |
3607-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: AES Antibody: Adhesion to extracellular matrix regulates cell survival through both integrin engagement and appropriate cell spreading. Anoikis is the molecular mechanism of apop-tosis induced by integrin detachment. Amino-terminal enhancer of split (AES) is a member of the Groucho/ transducin-like enhancer of split (TLE) family of transcriptional regulators, a group of transcriptional co-repressors that play important roles in neurogenesis, segmentation, and sex determination. AES forms a complex with Bit1 (Bcl-2 inhibitor of transcription 1), a mitochondrial protein that is released into the cytoplasm upon onset of apoptosis. It has been suggested that this complex turns off a survival-promoting gene transcription program controlled by the TLE protein family. Interestingly, apoptosis of cells transfected with AES and Bit1 could be inhibited if the cells were allowed to attach to fibronectin through the alpha5beta1 integrin suggesting that the Bit1-AES pathway contributing to anoikis is regulated by integrins, and in particular, the alpha5beta1 integrin. |
AES Antibody |
3607-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: AES Antibody: Adhesion to extracellular matrix regulates cell survival through both integrin engagement and appropriate cell spreading. Anoikis is the molecular mechanism of apop-tosis induced by integrin detachment. Amino-terminal enhancer of split (AES) is a member of the Groucho/ transducin-like enhancer of split (TLE) family of transcriptional regulators, a group of transcriptional co-repressors that play important roles in neurogenesis, segmentation, and sex determination. AES forms a complex with Bit1 (Bcl-2 inhibitor of transcription 1), a mitochondrial protein that is released into the cytoplasm upon onset of apoptosis. It has been suggested that this complex turns off a survival-promoting gene transcription program controlled by the TLE protein family. Interestingly, apoptosis of cells transfected with AES and Bit1 could be inhibited if the cells were allowed to attach to fibronectin through the alpha5beta1 integrin suggesting that the Bit1-AES pathway contributing to anoikis is regulated by integrins, and in particular, the alpha5beta1 integrin. |
AES Antibody |
3609-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: AES Antibody: Adhesion to extracellular matrix regulates cell survival through both integrin engagement and appropriate cell spreading. Anoikis is the molecular mechanism of apop-tosis induced by integrin detachment. Amino-terminal enhancer of split (AES) is a member of the Groucho/ transducin-like enhancer of split (TLE) family of transcriptional regulators, a group of transcriptional co-repressors that play important roles in neurogenesis, segmentation, and sex determination. AES forms a complex with Bit1 (Bcl-2 inhibitor of transcription 1), a mitochondrial protein that is released into the cytoplasm upon onset of apoptosis. It has been suggested that this complex turns off a survival-promoting gene transcription program controlled by the TLE protein family. Interestingly, apoptosis of cells transfected with AES and Bit1 could be inhibited if the cells were allowed to attach to fibronectin through the alpha5beta1 integrin suggesting that the Bit1-AES pathway contributing to anoikis is regulated by integrins, and in particular, the alpha5beta1 integrin. |
AES Antibody |
3609-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: AES Antibody: Adhesion to extracellular matrix regulates cell survival through both integrin engagement and appropriate cell spreading. Anoikis is the molecular mechanism of apop-tosis induced by integrin detachment. Amino-terminal enhancer of split (AES) is a member of the Groucho/ transducin-like enhancer of split (TLE) family of transcriptional regulators, a group of transcriptional co-repressors that play important roles in neurogenesis, segmentation, and sex determination. AES forms a complex with Bit1 (Bcl-2 inhibitor of transcription 1), a mitochondrial protein that is released into the cytoplasm upon onset of apoptosis. It has been suggested that this complex turns off a survival-promoting gene transcription program controlled by the TLE protein family. Interestingly, apoptosis of cells transfected with AES and Bit1 could be inhibited if the cells were allowed to attach to fibronectin through the alpha5beta1 integrin suggesting that the Bit1-AES pathway contributing to anoikis is regulated by integrins, and in particular, the alpha5beta1 integrin. |
AES Antibody |
36095-100ul |
SAB |
100ul |
EUR 302.4 |
AES Antibody |
1-CSB-PA973928 |
Cusabio |
|
|
|
Description: A polyclonal antibody against AES. Recognizes AES from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
AES Antibody |
1-CSB-PA551903 |
Cusabio |
|
|
|
Description: A polyclonal antibody against AES. Recognizes AES from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
AES Antibody |
1-CSB-PA001405ESR2HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against AES. Recognizes AES from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
AES Antibody |
R35917-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Amino-terminal enhancer of split, AES-1 |
AES Antibody |
E036095 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
AES Antibody |
E97874 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
AES Antibody |
36095 |
SAB |
100ul |
EUR 319 |
AES Antibody |
24349 |
SAB |
100ul |
EUR 479 |
AES Antibody |
24350 |
SAB |
100ul |
EUR 479 |
AES Rabbit pAb |
A7874-100ul |
Abclonal |
100 ul |
EUR 369.6 |
AES Rabbit pAb |
A7874-200ul |
Abclonal |
200 ul |
EUR 550.8 |
AES Rabbit pAb |
A7874-20ul |
Abclonal |
20 ul |
EUR 219.6 |
AES Rabbit pAb |
A7874-50ul |
Abclonal |
50 ul |
EUR 267.6 |
AES Rabbit pAb |
E2507874 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
AES Blocking Peptide |
33R-3414 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AES antibody, catalog no. 70R-1059 |
AES Blocking Peptide |
33R-3767 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AES antibody, catalog no. 70R-7912 |
Polyclonal AES Antibody |
AMM08746G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AES . This antibody is tested and proven to work in the following applications: |
Polyclonal AES Antibody |
AMM08747G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AES . This antibody is tested and proven to work in the following applications: |
AES Conjugated Antibody |
C36095 |
SAB |
100ul |
EUR 476.4 |
AES Polyclonal Antibody |
ABP57720-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of AES from Human, Mouse, Rat. This AES antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human AES protein |
AES Polyclonal Antibody |
ABP57720-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of AES from Human, Mouse, Rat. This AES antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human AES protein |
AES Polyclonal Antibody |
ABP57720-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of AES from Human, Mouse, Rat. This AES antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human AES protein |
AES Polyclonal Antibody |
ES10992-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against AES from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
AES Polyclonal Antibody |
ES10992-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against AES from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
AES Polyclonal Antibody |
E11-202046 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
AES protein (His tag) |
80R-1712 |
Fitzgerald |
50 ug |
EUR 366 |
Description: Purified recombinant Human AES protein |
Rat AES shRNA Plasmid |
20-abx985519 |
Abbexa |
|
|
|
Human AES shRNA Plasmid |
20-abx950120 |
Abbexa |
|
|
|
Mouse AES shRNA Plasmid |
20-abx970657 |
Abbexa |
|
|
|
Aes (GFP-tagged) - Mouse amino-terminal enhancer of split (Aes), (10ug) |
MG217929 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES Recombinant Protein (Rat) |
RP189452 |
ABM |
100 ug |
Ask for price |
AES Recombinant Protein (Mouse) |
RP114653 |
ABM |
100 ug |
Ask for price |
AES Recombinant Protein (Human) |
RP036493 |
ABM |
100 ug |
Ask for price |
AES Rabbit Polyclonal Antibody |
55355 |
SAB |
100ul |
EUR 439 |
Aes (untagged ORF) - Rat amino-terminal enhancer of split (Aes), (10 ug) |
RN201994 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (untagged)-Human amino-terminal enhancer of split (AES), transcript variant 2 |
SC119415 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (untagged)-Human amino-terminal enhancer of split (AES), transcript variant 1 |
SC307835 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (untagged)-Human amino-terminal enhancer of split (AES), transcript variant 3 |
SC307836 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aes (untagged) - Mouse amino-terminal enhancer of split (Aes), transcript variant 2 |
MC226221 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES Buffer 0.3M, pH 8.5 |
40120015-1 |
Bio-WORLD |
100 mL |
EUR 36.33 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 8.5 |
40120015-2 |
Bio-WORLD |
250 mL |
EUR 64.02 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 8.5 |
40120015-3 |
Bio-WORLD |
500 mL |
EUR 84.96 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.0 |
40120017-1 |
Bio-WORLD |
100 mL |
EUR 36.33 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.0 |
40120017-2 |
Bio-WORLD |
250 mL |
EUR 64.02 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.0 |
40120017-3 |
Bio-WORLD |
500 mL |
EUR 84.96 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.5 |
40120018-1 |
Bio-WORLD |
100 mL |
EUR 36.33 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.5 |
40120018-2 |
Bio-WORLD |
250 mL |
EUR 64.02 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
AES Buffer 0.3M, pH 9.5 |
40120018-3 |
Bio-WORLD |
500 mL |
EUR 90.14 |
|
Description: 2-Aminoethanesulfonic acid; 2-Aminoethylsulfonic acid; 2-Sulfoethylamine |
Aes ORF Vector (Rat) (pORF) |
ORF063152 |
ABM |
1.0 ug DNA |
EUR 607.2 |
AES (C-term) Rabbit pAb |
E2612591 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
AES ORF Vector (Human) (pORF) |
ORF012165 |
ABM |
1.0 ug DNA |
EUR 424.8 |
Aes ORF Vector (Mouse) (pORF) |
ORF038219 |
ABM |
1.0 ug DNA |
EUR 607.2 |
[KO Validated] AES Rabbit pAb |
A19944-100ul |
Abclonal |
100 ul |
EUR 492 |
[KO Validated] AES Rabbit pAb |
A19944-200ul |
Abclonal |
200 ul |
EUR 685.2 |
[KO Validated] AES Rabbit pAb |
A19944-20ul |
Abclonal |
20 ul |
EUR 265.2 |
[KO Validated] AES Rabbit pAb |
A19944-50ul |
Abclonal |
50 ul |
EUR 344.4 |
Human AES knockout cell line |
ABC-KH0360 |
AcceGen |
1 vial |
Ask for price |
Description: Human AES knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human AES Protein Lysate 20ug |
IHUAESPLLY20UG |
Innovative research |
each |
EUR 213 |
|
Description: Human AES Protein Lysate 20ug |
Human AES knockdown cell line |
ABC-KD0360 |
AcceGen |
1 vial |
Ask for price |
Description: Human AES knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Polyclonal AES Antibody (C-term) |
APR14860G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AES (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal AES Antibody (N-Term) |
APR14862G |
Leading Biology |
0.1 mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human AES (N-Term). This antibody is tested and proven to work in the following applications: |
AES (GFP-tagged) - Human amino-terminal enhancer of split (AES), transcript variant 2 |
RG212475 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (GFP-tagged) - Human amino-terminal enhancer of split (AES), transcript variant 3 |
RG213043 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (GFP-tagged) - Human amino-terminal enhancer of split (AES), transcript variant 1 |
RG217378 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aes (Myc-DDK-tagged ORF) - Rat amino-terminal enhancer of split (Aes), (10 ug) |
RR201994 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Aes (mGFP-tagged) - Mouse amino-terminal enhancer of split (Aes) |
MR217929L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (Myc-DDK-tagged)-Human amino-terminal enhancer of split (AES), transcript variant 3 |
RC213043 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (Myc-DDK-tagged)-Human amino-terminal enhancer of split (AES), transcript variant 2 |
RC212475 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES (Myc-DDK-tagged)-Human amino-terminal enhancer of split (AES), transcript variant 1 |
RC217378 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aes (myc-DDK-tagged) - Mouse amino-terminal enhancer of split (Aes), transcript variant 2 |
MR228432 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Compound 0120-0020 |
T131683-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Compound 0120-0020 |
Compound 0120-0020 |
T131683-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Compound 0120-0020 |
Compound 0120-0020 |
T131683-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Compound 0120-0020 |
Compound 0120-0020 |
T131683-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Compound 0120-0020 |
Compound 0120-0020 |
T131683-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Compound 0120-0020 |
Compound 0120-0018 |
T131684-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Compound 0120-0018 |
Compound 0120-0018 |
T131684-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Compound 0120-0018 |
Compound 0120-0018 |
T131684-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Compound 0120-0018 |
Compound 0120-0018 |
T131684-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Compound 0120-0018 |
Compound 0120-0018 |
T131684-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Compound 0120-0018 |
Compound N060-0120 |
T131220-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
Description: Compound N060-0120 |
Compound N060-0120 |
T131220-1g |
TargetMol Chemicals |
1g |
Ask for price |
Description: Compound N060-0120 |
Compound N060-0120 |
T131220-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
Description: Compound N060-0120 |
Compound N060-0120 |
T131220-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
Description: Compound N060-0120 |
Compound N060-0120 |
T131220-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
Description: Compound N060-0120 |
Lenti ORF clone of Aes (Myc-DDK-tagged) - Mouse amino-terminal enhancer of split (Aes) |
MR217929L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aes sgRNA CRISPR Lentivector set (Rat) |
K6789301 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Aes sgRNA CRISPR Lentivector set (Mouse) |
K4753001 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
AES sgRNA CRISPR Lentivector set (Human) |
K0054101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Polyclonal AES antibody - C-terminal region |
AMM08748G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AES - C-terminal region. This antibody is tested and proven to work in the following applications: |
Polyclonal Aes Antibody - N-terminal region |
AMM08749G |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Aes - N-terminal region. This antibody is tested and proven to work in the following applications: |
Polyclonal AES / Groucho Antibody (C-Terminus) |
AMM08744G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human AES / Groucho (C-Terminus). This antibody is tested and proven to work in the following applications: |
Polyclonal AES / Groucho Antibody (N-Terminus) |
AMM08745G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human AES / Groucho (N-Terminus). This antibody is tested and proven to work in the following applications: |
ARP32323_P050 - AES antibody - middle region (ARP32323_P050) |
ARP32323_P050 |
Aviva Systems Biology |
100ul |
EUR 389 |
|
Aes 3'UTR GFP Stable Cell Line |
TU151481 |
ABM |
1.0 ml |
Ask for price |
AES 3'UTR GFP Stable Cell Line |
TU050422 |
ABM |
1.0 ml |
EUR 1672.8 |
Aes 3'UTR GFP Stable Cell Line |
TU250361 |
ABM |
1.0 ml |
Ask for price |
Lenti ORF clone of Aes (mGFP-tagged ORF) - Rat amino-terminal enhancer of split (Aes), (10 ug) |
RR201994L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AES Protein Vector (Rat) (pPM-C-HA) |
PV252608 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Rat) (pPB-C-His) |
PV252606 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Rat) (pPB-N-His) |
PV252607 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Rat) (pPM-C-His) |
PV252609 |
ABM |
500 ng |
EUR 723.6 |
Lenti ORF particles, Aes (GFP-tagged) - Mouse amino-terminal enhancer of split (Aes), 200ul, >10^7 TU/mL |
MR217929L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
AES Protein Vector (Human) (pPM-C-HA) |
PV048659 |
ABM |
500 ng |
EUR 577.2 |
AES Protein Vector (Mouse) (pPM-C-HA) |
PV152876 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Human) (pPB-C-His) |
PV048657 |
ABM |
500 ng |
EUR 577.2 |
AES Protein Vector (Human) (pPB-N-His) |
PV048658 |
ABM |
500 ng |
EUR 577.2 |
AES Protein Vector (Human) (pPM-C-His) |
PV048660 |
ABM |
500 ng |
EUR 577.2 |
AES Protein Vector (Mouse) (pPB-C-His) |
PV152874 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Mouse) (pPB-N-His) |
PV152875 |
ABM |
500 ng |
EUR 723.6 |
AES Protein Vector (Mouse) (pPM-C-His) |
PV152877 |
ABM |
500 ng |
EUR 723.6 |
AES 3'UTR Luciferase Stable Cell Line |
TU000422 |
ABM |
1.0 ml |
EUR 1672.8 |
Aes 3'UTR Luciferase Stable Cell Line |
TU101481 |
ABM |
1.0 ml |
Ask for price |
Aes 3'UTR Luciferase Stable Cell Line |
TU200361 |
ABM |
1.0 ml |
Ask for price |
AES Protein Vector (Human) (pPB-His-MBP) |
PV320286 |
ABM |
500 ng |
EUR 577.2 |
AES Protein Vector (Human) (pPB-His-GST) |
PV320287 |
ABM |
500 ng |
EUR 577.2 |
Lenti-ORF clone of AES (mGFP-tagged)-Human amino-terminal enhancer of split (AES), transcript variant 1 |
RC217378L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Aes sgRNA CRISPR Lentivector (Rat) (Target 1) |
K6789302 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Aes sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6789303 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Aes sgRNA CRISPR Lentivector (Rat) (Target 3) |
K6789304 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Human Amino-terminal enhancer of split (AES) |
1-CSB-EP001405HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Amino-terminal enhancer of split(AES) expressed in E.coli |
Aes sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K4753002 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Aes sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K4753003 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Aes sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4753004 |
ABM |
1.0 ug DNA |
EUR 184.8 |
AES sgRNA CRISPR Lentivector (Human) (Target 1) |
K0054102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
AES sgRNA CRISPR Lentivector (Human) (Target 2) |
K0054103 |
ABM |
1.0 ug DNA |
EUR 184.8 |
AES sgRNA CRISPR Lentivector (Human) (Target 3) |
K0054104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Amino-terminal enhancer of split (AES) Antibody |
20-abx210483 |
Abbexa |
|
|
|
Amino-terminal enhancer of split (AES) Antibody |
20-abx210484 |
Abbexa |
|
|
|
Amino-Terminal Enhancer of Split (AES) Antibody |
20-abx225017 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
Monoclonal AES Antibody (monoclonal) (M02), Clone: 10 |
APR14861G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human AES (monoclonal) (M02). The antibodies are raised in mouse and are from clone 10. This antibody is applicable in E |
Amino-Terminal Enhancer of Split (AES) Antibody |
abx027807-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Amino-Terminal Enhancer of Split (AES) Antibody |
abx027807-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Amino-Terminal Enhancer of Split (AES) Antibody |
20-abx320627 |
Abbexa |
|
|
|
Amino-Terminal Enhancer of Split (AES) Antibody |
abx431308-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Amino-Terminal Enhancer of Split (AES) Antibody |
20-abx007180 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
AES Antibody / Amino-terminal enhancer of split |
RQ4533 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
Description: The AES gene is mapped to 19p13.3. The protein encoded by this gene is similar in sequence to the amino terminus of Drosophila enhancer of split groucho, a protein involved in neurogenesis during embryonic development. The encoded protein, which belongs to the groucho/TLE family of proteins, can function as a homooligomer or as a heteroologimer with other family members to dominantly repress the expression of other family member genes. Three transcript variants encoding different isoforms have been found for this gene. |
Lenti ORF clone of Aes (Myc-DDK-tagged ORF) - Rat amino-terminal enhancer of split (Aes), (10 ug) |
RR201994L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF particles, Aes (GFP-tagged ORF) - Rat amino-terminal enhancer of split (Aes), 200ul, >10^7 TU/mL |
RR201994L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
ARP36553_T100-25UL - AES Antibody - C-terminal region |
ARP36553_T100-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
ARP32322_P050-25UL - Aes Antibody - N-terminal region |
ARP32322_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
ARP37710_P050-25UL - Aes Antibody - C-terminal region |
ARP37710_P050-25UL |
Aviva Systems Biology |
25ul |
EUR 99 |
|
Lenti ORF particles, Aes (Myc-DDK-tagged) - Mouse amino-terminal enhancer of split (Aes), 200ul, >10^7 TU/mL |
MR217929L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Collectively, our findings not only offer systems biology approaches based drug target identification, but also provide the new clues for developing novel inhibitors for future breast cancer research.